• -
42 Results
Medical law
Promoted Yet Unproven: How State Laws Expand Access to Unchecked Stem Cell Interventions
The safety and efficacy of many stem cell treatments remain unproven by the FDA, yet state laws promote access and use of these unchecked and potentially harmful treatments. Fellow Kirstin R.W. Matthews summarizes her recent publication in a new commentary — outlining public health consequences of these state laws and calling for scientific societies’ advocacy in state policymaking.
Kirstin R.W. Matthews May 13, 2024
Texas State Capitol Building in Austin, TX
Where Are the Majority Who Support Vaccines?
The number of anti-vaccine bills filed in Texas has risen, yet many Texans support vaccine policy. Fellow Kirstin R.W. Matthews and nonresident scholar Rekha Lakshmanan examine the stakes of legislative engagement in public health initiatives and provide a call to action for Texans to embrace public health as an act of freedom.
Kirstin R.W. Matthews, Rekha Lakshmanan April 29, 2024
Financial graph and chart hologram
Biden Should Reengage on International Digital Trade Rules
The Office of the United States Trade Representative recently stepped back from ongoing negotiations on digital trade at the World Trade Organization, citing unsettled domestic policy, and suspended support for digital trade rules in the Indo-Pacific Economic Framework too. But if the U.S. wants to be a part of the conversation, it should reengage and help craft rules flexible enough to meet its future domestic policy needs, writes nonresident fellow Simon Lester.
Simon Lester March 7, 2024
Lab sample pipette
One Easy Way to Increase Transparency in Human Embryo Research
For research involving human embryos and other controversial subjects, science journals should require ethics statements from researchers detailing research oversight, what embryos were used, how many and for how long. This will help increase transparency and improve communication with the public, writes Science and Technology Policy Fellow Kirstin R.W. Matthews.
Kirstin R.W. Matthews January 9, 2024
Container
Was There a Free Trade Era, and Is It Over?
Despite recent claims that “free trade is dead,” fellow Simon Lester explains that America was never close to anything resembling free trade in the first place. Instead, current U.S. trade policy, just like past policy, reflects a messy mix of free market and industrial policy views.
Simon Lester July 13, 2023
Stem cell pipette
The Nobel Science Prizes: The Good, the Bad, the Ugly
To better reflect the iterative collaboration necessary for scientific progress, the Nobel Prize must expand its recognition to the many contributors of winning discoveries as well as diversify the selection committee, thereby also expanding recognition of the work of underrepresented minorities, argues this Baker Institute Blog post.
Kirstin R.W. Matthews, Kenneth M. Evans, Flora Naylor, Daniel Moralí October 13, 2021